The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
about
Virus evolution and transmission in an ever more connected worldA systematic review of reported reassortant viral lineages of influenza AIota-carrageenan is a potent inhibitor of influenza A virus infectionOseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a reviewDrug resistance in influenza A virus: the epidemiology and management.Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors.Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009Peramivir for the treatment of influenza.Antivirals in seasonal and pandemic influenza--future perspectives.Contrasting the epidemiological and evolutionary dynamics of influenza spatial transmissionEvolution in health and medicine Sackler colloquium: The comparative genomics of viral emergence.Molecular epidemiology of influenza A/H3N2 viruses circulating in Mexico from 2003 to 2012Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesThe landscape genetics of infectious disease emergence and spread.Identification of novel compounds against an R294K substitution of influenza A (H7N9) virus using ensemble based drug virtual screeningInvestigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence.Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection.Toward a quantitative understanding of viral phylogeography.Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome.Theoretical aspects of immunity.Influenza reverse genetics: dissecting immunity and pathogenesis.Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.Mechanistic insight into the h(2)o/d (2)o isotope effect in the proton transport of the influenza virus m2 protein.Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.A New Strategy to Reduce Influenza Escape: Detecting Therapeutic Targets Constituted of Invariance Groups.Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.Surveillance of human influenza A(H3N2) virus from 1999 to 2009 in southern Italy.Emerging influenza antiviral resistance threats.Implications of segment mismatch for influenza A virus evolution.Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians.Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds
P2860
Q24277617-0C71A55A-936F-4C63-B4C9-37474F8E8600Q26770895-FD2AACB1-A7C7-440A-95DD-12FAE0EADC9EQ28744254-935C80DD-7915-4017-B8E7-FFA5B6E0EB4AQ30224096-6DE11DC5-4A75-4629-8D5D-E2A23DE678CEQ30234600-C6E234A4-1566-4459-88CC-4FFC925B230BQ30355434-32431F78-482D-4D76-950F-18EE3D618F54Q30367631-1D6BB5B5-3678-477D-9A2D-A91589EB9635Q30367861-29BDB265-4635-4F0D-813A-D4BFBD5BA32BQ30382408-F4D1ACB9-8BE8-45DD-97F3-E5CF5F8A937BQ30391963-FA4AF9E0-F0AA-4868-A69A-DB1F701B3C7DQ30402874-77F8E0C0-049B-4409-9A96-1D8E0BD49A24Q30413154-82D4CA16-4E01-414A-B24C-1AD656570B41Q30425358-4C05AF97-9105-4A77-B49C-452287784C66Q30426783-1048C4DA-405D-43DE-AA89-A28482CD53B5Q33844462-F101B505-39F1-485A-8281-5153CA5554F5Q33975031-858DDC22-652B-4253-A096-998A5AE274B1Q34028343-10A2B2B0-8096-44BF-88AE-3DAE7CA8F61AQ34329204-DCD04748-2D00-440F-84F8-9784E84FB3F5Q34694826-A4DF30F5-A19D-4C2B-A83C-6C6C8A61E79EQ34942905-AC805752-8820-404B-9D0E-3765DCD23EDEQ35624840-565B710A-B5FD-4347-8DFF-DBBF3AF4AF35Q35677516-90BA4BFE-CE48-4C22-B585-DDADF977235EQ35854178-E3F3E4F3-8FCB-4317-A63B-4E5354C2D95BQ36754908-F9735BBE-988E-402F-89DD-AEAD8A7FBA43Q37995258-BF4C85F3-20BF-409F-AFF8-E23557AFD3CDQ38188084-7B449471-60D2-448D-A47C-ED65C8652F83Q38627487-4DAABE64-B4D8-4FC9-AEB4-634E90443D10Q39765493-C696AA99-89D4-4437-867F-00D011F22A48Q40150636-AF4C3D39-70B7-4DCE-B5F0-0B653FC507DFQ40309803-272686A2-D97C-4719-BF5D-13E6D0815D02Q42228631-150D9CA8-7D68-41CE-B80C-28E6CCAB2656Q42250266-A84D9356-7706-4BDE-B645-64936D19970FQ42725866-E204D1F9-F9E7-4500-826F-C1FFBD0EC9A1Q47290634-D4F29001-F63D-44E0-A3A5-80BA61A3501AQ47548869-CCB24147-6220-4E4F-9F06-F090F1D73A8CQ56535644-52F2797E-63B5-4A97-B95D-A6F618891997
P2860
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@en
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@nl
type
label
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@en
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@nl
prefLabel
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@en
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@nl
P2860
P50
P1433
P1476
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
@en
P2093
Martha I Nelson
P2860
P304
P356
10.1016/J.VIROL.2009.03.026
P407
P577
2009-04-24T00:00:00Z